These recordings of an August 1, 2020, LIVESTREAM event provide information on the treatment of hospitalized patients with severe or life-threatening COVID-19. Topics covered include the history and evolution of convalescent plasma therapies; implementation of the ongoing expanded access program for COVID-19 patients; current data; blood bank and donor recruitment strategies; and world perspectives on treatment of COVID-19 patients with plasma.
August 1, 2020 LIVESTREAM Recordings | |
---|---|
Welcome & Introduction R.Scott Wright, M.D., Mayo Clinic, Minnesota | |
History of Convalescent Plasma Arturo Casadevall, M.D., Ph.D., Johns Hopkins | |
Thoughts on the Design and Background of EAP from the US FDA Peter Marks, M.D., Ph.D, Food and Drug Administration | |
Update on EAP – Safety Data and Enrollment Michael J. Joyner, M.D., Mayo Clinic, Minnesota | |
Panel Discussion Arturo Casadevall, M.D., Ph.D., Peter Marks, M.D., Rickey Carter, Ph.D. and Liise-anne Pirofski, M.D. Moderators: R. Scott Wright, M.D. & C. Scott Collins, M.D. | |
Organization of the Team and Data, How it was Done Jonathon (Jack) Senefeld, Ph.D., Mayo Clinic, Minnesota Katelyn A. Bruno, Ph.D., Mayo Clinic, Florida | |
Blood Bank/Donor Recruitment Camille van Buskirk, M.D., Mayo Clinic, Minnesota Kathryn F. Larson, M.D., Mayo Clinic, Minnesota | |
Outcomes Rickey E. Carter, Ph.D., Mayo Clinic, Florida DeLisa Fairweather, Ph.D., Mayo Clinic Florida | |
International Perspective Hiba Saud AlHumaidan, M.D., Sheikh Khalifa Medical City, Abu Dhabi, UAE | |
The Landscape of Apps and AI’s for COVID Tracking Suraj Kapa, M.D., Mayo Clinic, Minnesota |